Pathogenesis of autoantibodies in inflammatory myopathies.
PURPOSE OF REVIEW While autoantibodies targeting extracellular antigens, such as those in myasthenia gravis, are established mediators of disease, autoantibodies recognizing intracellular antigens in inflammatory myopathies have traditionally been considered nonpathogenic. This review examines evidence challenging that...